Antidepressants in bipolar
Antidepressants are prescription medicines used to lift depression. There is some evidence that they help bipolar lows, but the average benefit is small and varies between medicines and people.
They can also tip mood into a high or a mixed state, where low and high symptoms occur together. In bipolar they are usually combined with a medicine that protects against highs, with early checks on sleep, mood and side effects.1,2
Antidepressants affect the activity of chemicals involved in communication between nerve cells. Several commonly used medicines act mainly on serotonin; others also act on noradrenaline. These chemicals are involved in mood and emotion. The choice depends on what has helped before, the type of bipolar and the effects the person can manage.3
What they help with
Antidepressants can be considered for a bipolar low when other established choices have been tried or when a person's history gives a reason to expect benefit. Studies show a small average benefit when they are added to another bipolar medicine, with some trials finding little extra improvement. The antidepressant evidence page weighs those findings and the risk of a high.1,4
In bipolar I, which includes a history of mania, the more severe high, treatment pairs the antidepressant with lithium, valproate or a suitable antipsychotic. Antipsychotics are medicines used for losing touch with reality, such as hearing voices, and also for mood episodes. The accompanying medicine helps protect against highs.2
Bipolar II includes hypomania, a less severe high, as well as lows. Sertraline or venlafaxine can sometimes be considered for a bipolar II low without high symptoms at the same time. The guideline places them after quetiapine, its first choice for that low. A history of becoming high on an antidepressant, current mixed symptoms or rapid cycling, meaning four or more episodes in a year, makes the balance less favourable.1,2
Common medicines in this class
Selective serotonin reuptake inhibitors, often shortened to SSRIs, act mainly on serotonin. Sertraline and fluoxetine belong to this group. Venlafaxine affects serotonin and noradrenaline. Bupropion is another type of antidepressant considered in bipolar treatment.2,3
Sertraline, sold as Lustral or Zoloft, can be considered for a bipolar II low without mixed symptoms; a trial found that a switch into hypomania remained possible whether people took sertraline, lithium or both.2,5
Fluoxetine, sold as Prozac, has well-established benefit combined with olanzapine for bipolar I depression, with olanzapine's sleepiness and weight effects part of the choice.1
Venlafaxine, sold as Efexor or Effexor, is a possible choice for a bipolar II low without mixed symptoms, but its class has a greater tendency to tip mood into a high than some other antidepressants, so previous switching and protection against highs deserve particular attention.1,2
Bupropion, sold as Wellbutrin in the US, can be considered as an addition to a medicine protecting against highs when other choices for a low have been tried; its benefit and switching risk still need review.2
Taking one day to day
Benefit is judged over weeks. Early appointments can check whether the low is easing, whether side effects are manageable and whether sleep or energy are changing towards a high. General NHS advice describes reviews every one to two weeks at the start; bipolar treatment also needs an agreed response to warning signs.2,3
The packet and prescription set the time, food instructions and missed-dose rule for the particular medicine. A pharmacist can help fit it to a daily routine. A few notes about sleep, interest, energy and ordinary tasks show whether it is helping with what matters, such as eating regularly or being able to work for a short period.
High or mixed symptoms after starting
A reduced need for sleep, feeling unusually driven, racing thoughts, faster speech, impulsive spending or becoming both low and agitated can signal a switch. Contacting the prescriber promptly allows the antidepressant and protection against highs to be reviewed; the guideline advises stopping the antidepressant when warning signs of mania appear. The prescriber needs to arrange that response rather than waiting for the next routine appointment.2
Agreeing in advance whom to contact, and what someone close might notice, makes those changes easier to act on. What helps when becoming high and what helps in a mixed state give practical ways to reduce stimulation and protect sleep while help is arranged. Immediate danger or being unable to stay safe needs urgent help now.6
Other side effects and interactions
Starting can bring nausea, bowel changes, sweating, disturbed sleep, dizziness or feeling more anxious and restless. Some effects ease after a few weeks. Others, including weight changes, sexual difficulties or feeling emotionally numb, may continue. These effects belong in a medicine discussion, where mood benefit and daily life can be weighed together.3
Simple food may be easier when feeling sick, and small sips of water may ease a dry mouth. Driving and machinery wait while someone is sleepy, dizzy or unable to concentrate. A pharmacist can review troublesome effects and check other medicines, supplements and herbal remedies, particularly St John's wort, another antidepressant or a painkiller. Alcohol can worsen symptoms or add to sleepiness.3
New suicidal thoughts or urges to self-harm need prompt help, especially after starting or changing treatment. In England, an urgent general-practitioner appointment or NHS 111's mental health option can arrange support; immediate danger or being unable to stay safe calls for 999 or an emergency department.3,6
Continuing or stopping
Continuing after a low improves is a separate choice. Some people benefit from fewer returning lows, while possible highs and continuing side effects still matter. Trials give mixed results for the overall balance. Previous response and the pattern of episodes help decide the plan.2,7
A planned stop usually means reducing the dose with the prescriber over weeks or months. Withdrawal, the effects of stopping, can include dizziness, electric-shock sensations, sickness, strange dreams, anxiety and low mood. Symptoms can resemble a returning episode. They often begin within days and ease over weeks, but some people have severe or much longer-lasting symptoms; a slower reduction can be discussed when this happens.3
A medicine discussion can begin with what has improved, what remains difficult, previous highs on antidepressants and what the person wants from a change. Pregnancy planning and breastfeeding need the particular antidepressant and the accompanying bipolar treatment considered together.3
Related: Medicines for bipolar · Antidepressant evidence · A medicine discussion.
Sources
- 1Yatham LN et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Published 14 March 2018.
- 2Keramatian K, Chithra NK, Yatham LN. The CANMAT and ISBD Guidelines for the Treatment of Bipolar Disorder: Summary and a 2023 Update of Evidence. Published October 2023.
- 3Antidepressants NHS
- 4Effectiveness of adjunctive antidepressant treatment for bipolar depression. Trial
- 5Switch Rates During Acute Treatment for Bipolar II Depression With Lithium, Sertraline, or the Two Combined: A Randomized Double-Blind Comparison. Sertraline trial
- 6Where to get urgent help for mental health NHS
- 7Duration of Adjunctive Antidepressant Maintenance in Bipolar I Depression. Continuation trial
Last updated 12 October 2026
